The Role of Treatment Assessments in AML Care
AML can be a difficult disease to treat. Getting the correct testing done is crucial to creating a treatment plan that is well-suited to tackle your AML. In this webinar hosted by the HealthTree Foundation for AML, Dr. James Dugan will talk about the tests AML patients should receive, what those tests can tell them about their AML, and how those tests can help inform their treatment plan.
Mary introduces the agenda for the event and featured speaker Dr. James Dugan.
Dr. James Dugan will talk to our Adult AML chapter about the role treatment assessments play in AML care
Type your questions in the chat and Dr. Dugan will answer them!
Mary Arnett
Mary joined HealthTree in 2022 as a part of HealthTree's team to help expand into all blood cancers. She now works as HealthTree's Volunteer & Community Outreach Manager, helping to engage and involve community members in HealthTree's mission. When she isn't working, she loves being the fun aunt to her 13 nieces and nephews, attending concerts, experimenting with new recipes in the kitchen, and traveling to explore new cities.
Dr. James Dugan
Dr. Dugan is a hematology/oncology specialist and the physician lead for the transplant and cellular therapy department for Novant Health Cancer Institute. He is a member of the American Society of Hematology, as well as the American Society for Transplant and Cellular therapy. His membership in these organizations keep him up to date on the latest research and treatment options in the field. He is also actively engaged in clinical research focused on acute leukemia, with the goal of finding new, targeted therapies that improve disease control and survival while limiting side effects and maintaining a good quality of life through treatment.